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Introduction
The clinical symptoms of the inflammatory disease of 
the pancreas, also called acute pancreatitis, may be only 
a mild abdominal pain or a severe disease is accompanied 
with lower blood pressure, metabolic disorders, sepsis, 
third spacing, organ failures, and shock (1). This is one 
of the most frequent surgical emergencies. It is a mild to 
severe, self-limiting, and sometimes fatal disorder. The 
mortality rate of acute pancreatitis is variable and has a 
range from 3.8% to 40% (2). Early diagnosis of pancreatitis 
and immediate initiation of treatments to decrease the 
mortality rate is critical (3). 
In recent years, there has been much attention concerning 
red blood cell distribution width (RDW) in clinical 
decisions as well as determining the severity of diseases 
(4,5). The normal reference value of RDW is 12.8% ± 
1.2% if reported in CV and 42.5 ± 3.5 if reported in SD. 
The quantitative variation in the size of circulating red 
blood cells (RBCs) is RDW. High values of RDW show 
a high variation in the size of circulating RBCs and may 
indicate various pathological conditions. Lower values of 
RDW statistically show higher uniformity of size in RBCs, 
although they are not clinically significant (5-8). In well-
established diseases, such as iron deficiency anemia, where 
the cells have uniformly been microcytic, RDW may reach 
the normal range. If, however, the treatment with iron 
begins, and the body responds to the treatment, RDW 
increases production of new normocytic cells until the 
treatment is completed, and normal hematopoiesis begins, 
where RDW returns to its normal range. RDW increases 
in other hematopoietic diseases, such as megaloblastic 
anemia, but it is normal in thalassemia (5,6).
Objectives
As an easy and cost-effective method, the measurement 
of RDW is routinely used as a part of complete blood 
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Abstract
Objective: In recent years, there has been a great attention concerning red blood cell 
distribution width (RDW) in clinical decisions as well as determining the severity of 
diseases. This study was conducted to evaluate the primary level of RDW to predict hospital 
mortality in pancreatitis.
Methods: This was a descriptive analytical study performed on 100 patients with acute 
pancreatitis in the emergency department of Imam Reza hospital of Tabriz University of 
Medical Sciences. In this study, the primary level of RDW in patients with acute pancreatitis 
presenting to the emergency ward was collected and after patients’ admission we followed 
them. Also, the admission outcome (mortality or discharge) of patients was registered, and 
finally we evaluated the predictive value of RDW in determining the patient’s outcome in 
hospital.
Results: In our study, 47 patients were male, and 53 patients were female. Mean RDW in 
patients was 13.82 ± 1.69. Five patients died during the study. Mean RDW in dead patients 
and other patients was 16.44 ± 4.22 and 13.68 ± 1.37, respectively (P < 0.001). The cut-
off point of 14.55 for RDW with 80% sensitivity and 85% specificity was determined for 
predicting mortality in patients. 
Conclusion: Based on our study results, the initial RDW level is an independent factor 
for predicting in-hospital mortality in pancreatitis but not for determining the need for 
surgery or admission to the intensive care unit (ICU). 
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count (CBC) test to assess patients. Recent studies have 
shown the significant value of RDW in the prediction of 
the mortality rate in patients admitted to the intensive 
care unit (ICU), patients with cardiovascular diseases, 
and community-acquired pneumonia. This study was 
conducted to evaluate the primary level of RDW which 
was checked in the emergency ward for predicting the 
hospital mortality in pancreatitis.
Methods
This descriptive-analytical study was performed on 
100 patients with acute pancreatitis in the emergency 
department of Imam Reza medical research and training 
hospital, Tabriz, East Azerbaijan, Iran. This hospital had 
an annual admission of 110 000 patients from January 
2014 to December 2014. The inclusion criteria included 
all patients admitted to the emergency ward with acute 
pancreatitis. We excluded patients with a positive history 
of anemia (iron, folate, or B12 deficiency), patients with 
hemolytic anemia, patients with liver disease, and patients 
who did not consent to participate in the study (Figure 
1). We used the sensitivity (48%) and specificity (96%) of 
RDW in prediction of mortality that was reported in Senol 
and colleagues’ study (4). In order to determine the sample 
size, with consideration the 1% prevalence of pancreatitis, 
80% power, and 95% CI, we used Dr. Lin Naing software 
(9). Sampling strategy was convenient method to reach 
final sample size.
All patients who went to the emergency ward and met 
the inclusion criteria were examined in this study. Upon 
admission, demographic specifications (including sex, age, 
symptoms, and signs) of the patients who complained of 
acute abdominal pain and were highly suspicious of having 
pancreatitis (symptoms such as nausea, vomiting, and 
epigastric tenderness) were recorded. Then, blood samples 
were delivered to the laboratory to measure their serum 
amylase and RDW. The serum amylase was measured 
using a photometer (Biotecnica BT- 3000, Italy), and 
RDW was measured using micromachining technology 
(Automated Hematology Analyzer, Japan). The normal 
level of serum amylase and its unit of measurement were 
respectively up to 100 and IU/L; the normal level of RDW 
and its unit of measurement were respectively 13.2 and 
percent. For confirming the diagnosis, we performed CT 
scan of the abdomen and pelvis with oral and intravenous 
contrast (Siemens SOMATOM Emotion 6, Germany) for 
all patients. All CT scans were reported by a radiologist, a 
faculty member of that university. All patients with acute 
pancreatitis were admitted to the ward, and the outcomes 
such as mortality, the incidence of complications, and the 
need for surgery were assessed. Also, we calculated Acute 
Physiology and Chronic Health Evaluation (APACHE) II 
score.
The obtained data were entered into SPSS 17.0 (SPSS 
Inc, Chicago). To describe the data, we used descriptive 
statistical analysis (frequency, percentage, mean ± SD). 
To compare quantitative data, we used t test and the ROC 
(receiver operating characteristic curve) was used to 
measure area under curve (AUC), sensitivity, specificity, 
positive predicting value (PPV), negative predicting value 
(NPV), Youden index (J), and cut-off point of RDW and 
APACHE II score for determining the need for surgery, 
admission to ICU, admission complication, and mortality. 
In all cases, the P value <0.05 was considered significant.
Results
We evaluated 100 patients with acute pancreatitis in this 
study. Of the patients, 47 were male, and 53 were female. 
The mean ± SD of the age of all patients was 56.31 ± 16.80 
years. About 26 patients had experienced gallstones. Mean 
duration of nil per os (NPO) in patients was 3.6 ± 1.4 days. 
The mean ± SD of the duration of hospitalization was 
6.47 ± 2.48 days. During the hospitalization, 14 patients 
needed to be admitted to ICU, 5 patients died (due to 
surgery complications, sepsis, and acute tubular necrosis), 
5 patients needed surgery (due to necrotizing pancreatitis 
or gallbladder stones), and 10 patients had admission 
complications (intubation, sepsis, and mortality). Table 1 
shows vital signs and paraclinical findings of the patients. 
Table 2 shows mean (±SD) of RDW and APACHE II score 
of patients based on admission to ICU, surgery need, 
admission complication, and mortality and comparison 
of them between groups. As shown in Table 2, there 
was a significant statistical difference between RDW 
and APACHE II score in patients who had admission 
complication and in-hospital mortality.
For predicting the admission complication in patients, 
we used the ROC curve to determine the value of RDW 
and APACHE II score. Figure 2A shows the predicting 
value of RDW for admission to the ICU, as the AUC was 
0.81 for RDW and 0.78 for APACHE II score. The cut-off 
point of 13.95 for RDW (80% sensitivity, 71% specificity, 
0.51 Youden index, 0.73 PPV, 0.78 NPV, 2.75 LR+, and 
3.55 LR-) and 8.5 for APACHE II score (90% sensitivity, 
67% specificity, 0.57 Youden index, 0.74 PPV, 0.87 NPV, 
2.72 LR+, and 6.7 LR-) was determined for predicting 
admission complications in patients. Figure 2B shows 
the predictive value of RDW and APACHE II score for 
Figure 1. Study flowchart.
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mortality in patients with acute pancreatitis, as the AUC 
was 0.81 for RDW and 0.88 for APACHE II score. The 
cut-off point of 14.55 for RDW (80% sensitivity, 85% 
specificity, 0.65 Youden index, 0.84 PPV, 0.81 NPV, 5.33 
LR+, and 4.25 LR-) and 9.5 for APACHE II score (80% 
sensitivity, 69% specificity, 0.49 Youden index, 0.72 PPV, 
0.77 NPV, 2.58 LR+, and 3.45 LR-) was determined for 
predicting mortality in patients. 
Discussion
Various scores were used to determine mortality or 
incidence of complications in patients with pancreatitis, 
including APACHE II score, Ranson criteria, and level 
of serum C-reactive protein (CRP). These scores, except 
CRP, are obtained through collecting various data 
in a time-consuming process and need complicated 
calculations (10-13). The level of RDW has been recently 
introduced for prediction of mortality rate in patients with 
pancreatitis (5,14,15).
Acute pancreatitis is mostly self-limiting, is accompanied 
with/out complications, and has a mortality rate lower 
than 2%. However, almost 20% of attacks progress to 
acute and severe pancreatitis. The overall mortality rate of 
pancreatitis was 4%-7% (10). In acute pancreatitis patients, 
the mortality is associated with multi-organ dysfunction 
syndrome (MODS) and septic complications. Over the 
recent years, the main cause of mortality is MODS. The 
mortality in these patients occurs in 2 stages: the first 
week when systemic inflammatory response syndrome 
(SIRS) and MODS occur, and the late stage after 1-3 weeks 
following the MODS accompanied with infections (5,16).
There are many studies on the relationship of mortality 
or complications in different patients with heart diseases, 
cancer, stroke, peripheral vascular,renal disease, infection, 
respiratory, and acute diseases as well as normal patients 
and normal populations with the primary level of RDW 
Table 1. Vital signs and paraclinical findings of the patients
Variables Minimum Maximum Mean ± SD
Systolic blood pressure (mm Hg) 90 185 125.94 ± 16.57
Diastolic blood pressure (mm Hg) 60 100 76.31 ± 9.92
Heart rate, bpm 60 115 82.66 ± 9.32
Respiratory rate (per minute) 12 24 16.48 ± 1.77
RDW (%) 11.20 23.80 13.82 ± 1.69
APACHE II score 1 25 7.94 ± 3.69
BUN (mmol/L) 6.00 109.00 19.04 ± 12.94
Cr (mg/dL) 0.50 13.50 1.2030 ± 1.30
BS (mg/dL) 76.00 1299.00 156.27 ± 135.79
Amylase (IU/L) 57.00 6500.00 1417.28 ± 1357.41
ALT (IU/L) 8.00 1110.00 112.22 ± 151.88
AST (IU/L) 12.00 1211.00 89.65 ± 143.00
ALP (IU/L) 83.00 1586.00 351.33 ± 280.38
LDH (IU/L) 201.00 2553.00 509.63 ± 288.08
Ca++ (meq/L) 0.10 10.80 8.68 ± 1.13
Total Bilirubin (mg/L) 0.20 24.00 2.52 ± 3.22
HCO3 (mmol/L) 9.00 32.10 19.52 ± 5.16
PaCO2 (mm Hg) 18.40 58.00 33.61 ± 9.13
pH 7.16 7.54 7.36 ± 0.08
Table 2. Mean (±SD) of RDW and APACHE II score of patients
Variables Frequency RDW (P value) APACHE II score (P value)
Admission to ICU
Yes 14 14.33 ± 1.26 9.28 ± 3.91
No 86 13.74 ± 1.75 (0.230) 7.72 ± 3.63 (0.142)
Need for surgery
Yes 5 13.78 ± 9.33 8.80 ± 1.79
No 95 13.82 ± 1.73 (0.954) 7.89 ± 3.76 (0.596)
Admission complication
Yes 10 15.61 ± 3.13 11.00 ± 2.94
No 90 13.62 ± 1.34 (˂0.001) 7.60 ± 3.62 (0.005)
Mortality
Yes 5 16.44 ± 4.22 15.20 ± 6.38
No 95 13.68 ± 1.37 (˂0.001) 7.56 ± 3.11 (˂0.001)
Abbreviations: ICU: intensive care unit, RDW: red cell distribution width, APACHE II: Acute Physiology and Chronic Health Evaluation.
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(17-19). Most of these studies conducting survival analysis 
introduced RDW as a determinant variable of mortality 
in patients. Moreover, RDW has been introduced as 
a predictor of complications, such as heart failure in 
myocardial infarction, although studies could not predict 
the severity of cancer or stroke with RDW (20-24), but 
RDW strongly predicts the mortality in patients with 
known stroke (25). In their study, Senol et al concluded 
that the level of RDW upon the admission of patients with 
acute pancreatitis was a useful factor for determining the 
mortality rate in these patients (4). Zorlu et al examined the 
level of RDW and stated that RDW was a predictive factor 
in patients with cardiopulmonary disorders, including 
coronary heart disease, acute myocardial infarction 
(AMI), acute and chronic heart failure, and pulmonary 
hypertension, and the high level of RDW increased the 
mortality rate in these patients (6). Jo et al concluded 
that the primary level of RDW significantly correlated 
with the mortality rate in patients with severe sepsis and 
septic shock patients and was significantly higher in dead 
patients (7). Wang et al conducted a study on mortality 
rate in patients admitted to the ICU and found that the 
high level of RDW was more correlated with mortality (8).
Our study results show that the cut-off point of RDW 
could not be determined in predicting the need for surgery 
and the need for admission to the ICU, while, the cut-off 
point of 14.55 for RDW with 80% sensitivity and 85% 
specificity was determined for predicting mortality and 
the cut-off point of 13.95 for RDW with 80% sensitivity 
and 71% specificity was determined for predicting 
admission complications. In this study, significant results 
were obtained only in determining the mortality and 
admission complications of patients on the basis of the 
initial level of RDW, while, RDW did not predict other 
outcomes. In our study, only 5 patients died. Also, our 
results revealed that the level of RDW in patients who 
were admitted to the ICU due to the severe symptoms or 
died due to the exacerbation of the disease was higher than 
that in other patients. This study was the second one, after 
Senol and colleagues’ study (4), which showed the value 
of the primary level of RDW in determining mortality in 
patients with acute pancreatitis.
One of the limitations was the impossibility of investigating 
all the cases presenting to the emergency ward when 
collecting samples. Moreover, there was no control group 
due to the descriptive design of the study. 
This study showed that the initial RDW level is an 
independent factor for predicting in-hospital mortality in 
pancreatitis but not for determining the need for surgery 
or admission to the ICU. However, further studies should 
be performed on a larger sample size and in other medical 
centers. 
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